Small maladaptations in cellular response to environmental stressors may underlie diseases like asthma. However, genomewide transcriptional profile comparisons between case and controls only highlight the quantitatively largest changes. Critical cellular homeostatic pathways may be upregulated modestly during normal adaptation to stress but insufficiently during disease. To discover such pathways in asthma, we utilized public information on differential response of primary bronchial epithelial cells from asthmatic or normal subjects to stressors like ozone and viral infections. Genes that were upregulated by stressor conditions in normal cells but were relatively downregulated in cells from asthmatic subjects were selected for further analysis. Either a stringent selection based on quantitative criterion or a nonstringent selection followed by network-based analysis was used. At the individual gene level, decay accelerating factor-1 (DAF-1, CD55) was identified and selected for validation. In a mouse model of allergic airway inflammation (AAI) resembling asthma, protein expression of CD55 was reduced compared with normal mice and returned to normal upon resolution of the allergic response. This was consistent with our finding of relative downregulation of CD55 in asthmatic compared with normal subjects. Interestingly, at a network level, the results pointed to possible abnormalities in the inositol signaling pathway, a critical cell signaling mechanism. In the mouse model of AAI, we found downregulation of inositol polyphosphate 4 phosphatase A (INPP4A), a critical member of the inositol signaling pathway. This and previous genetic evidence supports a role for inositol signaling abnormalities in asthma. In summary, logic-gated hypothesis-free exploration of published data sets may be valuable in discovery of novel disease-associated pathways.
A NUMBER OF STUDIES comparing gene expression profiles of asthmatic and nonasthmatic patients (or models) have recently been published (3, 13, 26 -28) . To increase confidence in the comparisons, restrictive statistical analyses are used and only the largest differences are reported. However, large effects in cellular or organismal functional may result from small concordant changes in multiple genes along important pathways. Also, direct comparison of the diseased state to the healthy state may miss important information. We considered a scenario in which healthy cells respond appropriately to environmental stress by upregulation of critical homeostatic functions while diseased cells, although similar at baseline, fail to suitably upregulate, causing maladaptation. Two approaches can be followed: first, a classical approach of selecting genes that show statistically significant variation that in large data sets leads to selection of only the largest variations after correction for multiple comparisons and second, looking for enrichment of processes and pathways. Since critical homeostatic functions may not be based on large variations in individual genes but may encompass changes across a wide network of genes, a combined two-pronged approach was evaluated for candidate gene/pathway discovery. At the first level a series of logical gates for suitable directional changes were used to create a nonrestrictive collation of candidate genes. These candidate genes were then either restricted for statistical significance or interrogated by network analysis for signatures across a number of genes linked together in a pathway. We applied this to asthma, where heightened responses to innocuous environmental triggers are well studied. The results of this investigation are presented.
METHODS
Computational model. We considered a hypothetical situation in which the normal response to a stress is transcriptional upregulation of critical genes and pathways that oppose the disturbance. We assume for the purpose of this scenario that RNA transcripts correlate to functional proteins and that this correlation is unaltered by disease. In a normalized RNA expression data set of normal subjects (NZ) where NZ i1 and NZi2 refer to original and poststress expression values of such a critical gene i, we expect that NZ i2 Ͼ NZi1. In an abnormal (disease) scenario in which some of these critical genes fail to upregulate and reach sufficient levels for maintenance of homeostasis, corresponding values for a data set from diseased subjects (DZ) are likely to be such that DZ i2 Ͻ NZi2. Furthermore, for the specific case of failure to upregulate from a normal baseline, it can be further stated that (NZ i2 Ϫ Nzi1) Ͼ (DZi2 Ϫ DZi1). This expected behavior of such maladapted critical homeostatic pathways can then be used to set a series of logical gates that would result in enrichment of these processes in the filtered data.
Candidate genes. We searched for data sets of gene expression profiling that compared the transcriptional patterns of normal and asthmatic subjects under a variety of circumstances and analyzed them for such differences. Data set GEO-470 has data regarding the effect of air, ozone, and rhinovirus infection on mRNA expression profiles of cultured epithelial cells obtained from normal or asthmatic subjects. Ozone and rhinovirus infection represent stressors to which asthmatic subjects are more sensitive than normal subjects, and it is possible that maladaptation is responsible for the difference. We screened GEO-470 for genes of interest based on the computational models. Raw intensity values were converted, log 10 transformed, and used for Z score calculation with the formula Zscore ϭ [V1 Ϫ mean(V1 . . . Vn)]/SD(V1 . . . Vn). The above formula was applied to both control and asthmatic groups. After Z score normalization, the data set was filtered for Affy controls, and probes with "absent" as well as "marginal" calls were removed from the analysis. For comparison, Z ratios were calculated [Zratio(asthma/control) ϭ (Zasthma Ϫ Zcontrol)/SD(Zasthma Ϫ Zcontrol)]. Similarly for time course comparisons, Z scores of the two time points were used to generate a Z ratio.
After transformation of the data set to Z scores, we selected all genes that were consistently higher in normal subjects than asthmatic subjects after stress (DZ i2 Ͻ NZi2)ozone AND RV and were upregulated in response to stress (NZi2 Ͼ NZi1)ozone OR RV, and the increase for normal subjects was greater than that of asthmatic subjects [(NZi2 Ϫ Nzi1)Ͼ (DZi2 Ϫ DZi1)]ozone OR RV. A total of 798 genes were identified by this approach and are referred to as the candidate gene list. This list was either subjected to pathways analysis (see Pathways analysis) or further restricted by only taking genes with Z ratio difference Ͼ 1.95 between asthmatic and normal subjects (post-ozone or post-virus Z score for normal subjects being greater than that for asthmatic subjects).
Pathways analysis. The candidate gene list was uploaded to Ingenuity Pathways Analysis (IPA) trial version (Ingenuity Systems, The Ifitm family is a striking example of a conserved gene cluster that appears to be functionally redundant during development. www.ingenuity.com) (25) . The reference set was Ingenuity Knowledge Base (Genes Only). Reported direct relationships from mammalian species in primary cells, cell lines, or tissue related to lung or immune cells were considered for building the networks. Significance was set at P Ͻ 0.05. Focus molecules placed in networks as identified in the default results and additional nonfocus members of the core networks from the candidate gene list were condensed into a list referred to as the pathways list. The functions and relationships represented by these genes were elucidated by a second core analysis using all reported relationships. These results were manually curated for accuracy and proper representation. For confirmation of results, the analysis was repeated with the freely available Pathway Express online tool that analyzes the input gene list against a reference gene list to identify pathways that contain a proportion of differentially expressed genes, based on a hypergeometric distribution (4, 9). The candidate gene list was queried against the array list, and the focus molecule list from IPA was queried against the candidate gene list and the array list. A Pathway Express-generated perturbation factor that takes into consideration the position of a gene on a pathway was used to rank the results. Default settings were used for all software unless specified.
Induction of experimental asthma in mice. Male BALB/c mice (8 -10 wk old) were obtained from the National Institute of Nutrition (Hyderabad, India) and acclimatized for a week before the experiments started. All animals were maintained as Western blot. For Western blot, total lung proteins were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred onto polyvinylidene fluoride membranes (Millipore). Transferred membrane was blocked with blocking buffer (3% skim milk in PBS with Tween 20), incubated with anti-decay accelerating factor-1 (DAF-1, CD55) (1:250, Santa Cruz Biotechnology, Santa Cruz, CA) or anti-inositol polyphosphate 4 phosphatase A (INPP4A) (Santa Cruz Biotechnology) followed by horseradish peroxidase-conjugated secondary antibodies (anti-rabbit for CD55, Sigma) and detected with diaminobenzidine-H2O2 (Sigma). ␣-Tubulin was used as a loading control. Signals were detected by spot densitometry (Alpha EaseFC software from Alpha Innotech).
RESULTS
The full candidate gene list containing 798 genes is provided in the supplemental data for this article 1 . Table 1 lists the genes 1 The online version of this article contains supplemental material. Fig. 3 . Antigen presentation signaling (A) and B cell proliferation (B) pathways were found to be enriched by Pathway Express analysis. Schematic flow charts are shown, with molecules matching to input list shown by shading. Notably, the phosphatidylinositol signaling pathway overlaps with these pathways.
that were significantly less expressed in stressed cells from asthmatic compared with normal subjects and were upregulated during stress in normal cells. Notably, many of these have functions that may be relevant in asthma and many map to asthma loci. Of these, CD55 was further tested in an experimental model of asthma because it is a known modulator of immune response. The CD55 gene encodes a protein involved in the regulation of the complement cascade by accelerating the decay of complement proteins, thereby disrupting the cascade and preventing damage to host cells (14) .
CD55 is deficient in acute allergically inflamed lungs.
To test the potential association of CD55 downregulation with asthma, we studied CD55 protein expression in lysates from lungs of normal control mice (Sham/PBS/Veh), mice with acute allergic airway inflammation (AAI) resembling asthma (OVA/OVA/Veh), and mice with resolution of AAI after steroid treatment (OVA/OVA/Dexa). CD55 expression was markedly reduced in inflamed lungs (Fig. 1) . Importantly, resolution of the allergic response after steroid treatment was associated with restoration of CD55 levels.
Unrestricted pathway analysis. Functional analysis of the candidate gene list by IPA showed that top three functions were cell signaling and cell-cell interaction, antigen presentation, and cell movement (Table 2) . Interestingly, these were followed by cell development and cell death. Associated canonical pathways included leukocyte extravasation signaling, tight junction signaling, B cell signaling, and Erk/MAPK signaling.
Restricted pathway analysis. With the assumption that the relevant pathways are more likely to be networked to each other than irrelevant false positives, the full candidate gene list was restricted by network analysis with IPA software to the focus molecules and members of the core networks, as described in METHODS. The reduced list containing 66 genes was referred to as the pathways list (Supplemental Data). Canonical pathways analysis of the pathways list showed that the top three canonical pathways were IL-12 signaling and production, NRF2-mediated oxidative stress response, and renin-angiotensin signaling (Table 3) . Cell proliferation and cell death were the top functions. This was interesting since all of these pathways and functions have been implicated in asthma in various studies but appear to be functionally distinct (2, 7, 11, 16 -18, 20 -23) . We further investigated whether there were shared motifs between these canonical pathways.
Network analysis of pathways. To understand core shared motifs within the enriched canonical pathways, we first manually analyzed the networks between the genes and pathways. The networks showed important links to the inositol signaling pathway. This was validated by an unsupervised analysis of the pathways list with Pathway Express, which confirmed a significant enrichment for the inositol signaling pathway (corrected P Ͻ 0.0001; Fig. 2 ). Pathway Express additionally identified B cell proliferation and Fc⑀ signaling pathways in the top three pathways, but these were indirectly related to inositol signaling based on our manual review (Fig. 3) . Within the inositol signaling pathway, we focused on the terminal step where phosphatidylinositol 3,4-bisphosphate is degraded to INPP4A is deficient in allergically inflamed lungs. To confirm whether downregulation of INPP4A could be associated with asthma, we performed Western blots on lung lysates from mice with AAI as well as normal control mice. We found that INPP4A is reduced in mice with AAI (Fig. 4) . Interestingly, alleviation of asthma conditions by steroid restores INPP4A expression.
DISCUSSION
In this study, we analyzed transcriptional profile data sets of the response of primary bronchial epithelial cells from asthmatic and normal subjects to cellular stress, looking for differences in upregulated homeostatic mechanisms. We looked for statistically significant differences in terms of changes in RNA transcripts as well as in terms of affected pathways and networks. The two approaches yielded different results, which is not unexpected. Table 1 summarizes the 18 genes that were significantly less expressed in stressed cells from asthmatic compared with normal subjects and were upregulated during stress in normal cells. This two-part algorithm finds genes that are part of compensatory homeostatic mechanisms (upregulated during stress in normal cells) and are different in asthma (significantly less expressed in stressed cells for asthmatic patients). CD55 was selected for experimental validation because it is a known anti-inflammatory molecule that ameliorates complement system-mediated injury (14) . It is already known that the complement system is activated in asthma, and genetic polymorphisms in the complement system have been related to asthma risk (8, 12) . We found that in a murine model of AAI resembling asthma, CD55 protein is downregulated. This confirmed our informatic observation that CD55 is relatively downregulated in asthma. We further speculate that oxidative stress, which is known to induce heme oxygenase 1 (HO-1), in turn leads to transcription of CD55 (5, 10) . Failure or inadequacy of this mechanism may predispose to asthma or lung inflammation, as has already been noted for HO-1 deficiency (5). The mechanisms may be through its known protective role in complement injury or other yet undiscovered functions. Simvastatin, which upregulates CD55, has been found to be effective in treating asthma in a mouse model, although other mechanisms have been implicated (14, 15) . The status of CD55 expression in human asthma is less clear. In a human asthma expression profile data set, GSE-4302, we found that CD55 RNA transcripts were ϳ1.6-fold more in airway biopsies from asthmatic subjects compared with control subjects (P Ͻ 0.05) and were restored to normal levels after inhaled steroid treatment. The differences between observations in mice and humans may be due to differences between expressions at protein (mouse) and RNA (human) levels, differences in type of inflammation (acute in the mouse model, chronic in humans), or the fact that CD55 may be transcriptionally upregulated during mild human asthma as a compensatory mechanism to oxidative stress and is restored to normal after asthma resolves. Since normal subjects in the GSE-4302 data set did not undergo any form of stress (ozone or infection), the data are not comparable to GEO-470. While the exact mechanisms are unclear, our findings suggest that CD55 is differentially regulated in asthma in vitro, in vivo in a mouse model, and in human bronchi. We speculate that oxidative stress and HO-1 are important determinants of CD55.
The pathways analysis yielded results complementary to the individual gene-based approach. This was expected since only modest changes are expected in critical upstream pathways and they may not be picked up individually. We identified the inositol signaling pathway to be potentially affected in asthma. Interestingly, the top pathways found by Pathway Express and IPA software were cell proliferation and synthesis. While there is evidence that cellular proliferation may be abnormal in asthma (2, 6, 22, 23) , we have focused on the inositol signaling pathway, which, as shown in Figs. 2 and 3 , is upstream to the other pathways identified in the analysis and is importantly related to proliferation.
While the inositol signaling pathway is not a classical asthma pathway, there is sufficient experimental evidence to indicate otherwise. Recently polymorphisms in INPP4A gene were reported to be associated with asthma in humans, possibly due to reduced protein stability (24) . This has been replicated in a mouse model in which asthma is associated with reduced INPP4A (Fig. 4) . Interestingly, INPP5D or Src homology 2 domain-containing inositol 5-phosphatase 1 (SHIP-1), identified by us as a focus molecule, is just upstream of INPP4A in the inositol signaling pathway, which further links to various other pathways (Fig. 5) . Experimentally, it is known that SHIP-1-deficient mice are prone to allergic inflammation (19) . Thus disturbances of inositol signaling in asthma are not just possible but likely.
In summary, a logic-gated but hypothesis-free analysis of freely available data reveals possibly important roles in the asthmatic process for some genes that have not been previously considered in that light. This highlights the wealth of data that is now available to researchers and hopefully encourages us to use better what we already have.
